Insiders Korro Bio, Inc.

Equities

KRRO

US5009461089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
49.15 ^USD	+7.20%		+34.55%	+2.55%

Jul. 01	Korro Bio Joins Russell 2000, 3000, Microcap Indexes	MT
Jul. 01	Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Value Index	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Korro Bio, Inc. Announces Resignation of Steve Colletti as Chief Scientific Officer, Effective August 2, 2024	Jun. 21	CI
Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer	May. 14	MT
Korro Bio, Inc. Announces the Appointment of Kemi Olugemo, M.D. as Chief Medical Officer	May. 14	CI
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio, Inc. Appoints Rachel Meyers as Board of Directors, Member of Nominating and Corporate Governance Committee	Nov. 28	CI
Frequency Therapeutics, Inc. Announces the Resignation of Christopher Loose as Chief Scientific Officer	23-07-31	CI
Frequency Therapeutics, Inc. Announces Board Changes	23-05-10	CI
Frequency Therapeutics, Inc. Appoints Christopher Loose, Ph.D., as Interim Chief Executive Officer	23-02-13	CI
Frequency Therapeutics, Inc. Announces Stepping Down of Carl P. Lebel, Ph.D. as Chief Development Officer, Effective March 31, 2023	23-02-13	CI
Actinogen Medical Appoints Medical Chief	23-01-31	MT
Voyager Therapeutics Names Peter Pfreundschuh Finance Chief	22-09-07	MT
Frequency Therapeutics, Inc. Appoints Kevin Franck as Senior Vice President of Strategic Marketing and New Product Planning	21-02-08	CI
Frequency Therapeutics Appoints Quentin McCubbin, Ph.D., as Chief Manufacturing Officer	21-01-19	CI
Frequency Therapeutics Appoints Cynthia Feldmann to Its Board of Directors	20-09-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Korro Bio, Inc.

Equities

KRRO

US5009461089

Insiders

Filters